Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy. Braz. J. Pharm. Sci. [Internet]. 2018 Dec. 20 [cited 2024 May 4];54(4):e17349. Available from: https://revistas.usp.br/bjps/article/view/159278